Attempts to detect Helicobacter pylori in atherosclerotic plaques

A Sulewska1, W Modrzejewski, O Kovalchuk

  • 1Clinic of Thoracic Surgery, Medical University of Bialystok, Poland.

Insights

This study investigated Helicobacter pylori presence in atherosclerotic plaques from coronary artery bypass grafting patients. No bacterial DNA was detected, suggesting H. pylori may not play a direct role in atherogenesis in this cohort.

Area of Science:

  • Cardiovascular Research
  • Infectious Disease Epidemiology
  • Atherosclerosis Pathogenesis

Background:

  • Cardiovascular and cerebrovascular diseases are leading causes of mortality globally.
  • Atherosclerosis is the underlying pathology for these conditions.
  • Recent research explores the link between bacterial infections, like Helicobacter pylori, and atherogenesis.

Purpose of the Study:

  • To evaluate the presence of Helicobacter pylori in atherosclerotic lesions.
  • To determine if H. pylori DNA can be detected in arterial plaque samples.
  • To investigate the potential role of H. pylori in coronary heart disease development.

Main Methods:

  • Samples of atherosclerotic changes were obtained via endarterectomy during coronary artery bypass grafting (CABG).
  • Polymerase Chain Reaction (PCR) technique was employed to detect H. pylori DNA.
  • Patient risk factors including hyperlipidemia, smoking, hypertension, obesity, and diabetes were recorded.

Main Results:

  • Helicobacter pylori DNA was not detected in any of the analyzed atherosclerotic plaque samples.
  • The study group comprised patients with common cardiovascular risk factors.

Conclusions:

  • The study found no evidence of Helicobacter pylori DNA in atherosclerotic plaques from patients undergoing CABG.
  • These findings do not support a direct role for H. pylori in the pathological process of atherosclerosis in this specific patient population.

Related Concept Videos

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...